To advance the development of innovative driver monitoring systems, it is essential to acquire multimodal data that includes driving behavior, driver states, well-being, and cognitive load. However, to achieve high-quality studies, robust...

The Laboratory for Bio-Micro Devices at Brigham and Women’s Hospital () develops drug releasing implantable intratumoral microdevices (IMD) [1]. Using MIKAIA®, they want to examine in a quantitative fashion how the cell subpopulations change...

Tomorrow’s healthcare isn’t just about the transformation into a fully digitized and interconnected system; it’s also about nurturing, approving, and implementing innovative digital medical products. To gain market approval, innovators must...

Welcome to our MIKAIA FAQs. We know that navigating a flexible digital pathology & spatial biology image analysis software like MIKAIA® can raise a lot of questions, and we’re here to help. Whether you’re looking for quick tips or...

Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s, characterized by the progressive loss of nerve cells. As the disease progresses, both motor and non-motor symptoms become more severe. The...